Nanosonics Limited
Nanosonics Limited (NNCSF) Revenue
Annual & quarterly revenue history · segment & region breakdown
NNCSF · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsNanosonics Limited trailing twelve-month (TTM) revenue is $0.39B, an increase of 17.01% year-over-year from $0.20B in FY2025.
Revenue trend
2025 – 2007 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-06-30 | $0.20B | +$0.03B | +17.01% |
| 2024-06-30 | $0.17B | +$0.00B | +1.49% |
| 2023-06-30 | $0.17B | +$0.05B | +39.91% |
| 2022-06-30 | $0.12B | +$0.02B | +16.15% |
| 2021-06-30 | $0.10B | +$0.00B | +3.72% |
| 2020-06-30 | $0.10B | +$0.02B | +18.22% |
| 2019-06-30 | $0.08B | +$0.02B | +38.61% |
| 2018-06-30 | $0.06B | -$0.01B | -10.16% |
| 2017-06-30 | $0.07B | +$0.02B | +57.74% |
| 2016-06-30 | $0.04B | +$0.02B | +92.65% |
Compare revenue vs peers
Medical - Instruments & SuppliesCompare NNCSF revenue against listed peers. Click any row to open that company's revenue tab.
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Nanosonics Limited receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Nanosonics Limited reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in AUD.
Data sourced from Nanosonics Limited's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
NNCSF revenue · 4 questionsNNCSF's trailing twelve-month (TTM) revenue is $0.39B. That is an increase of 17.01% year-over-year from $0.20B in FY2025.
▸ Source: FMP · Nanosonics Limited SEC filings · GAAP · Nanosonics Limited SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026